藥物成份

共有 21647 個藥物成份

Strip Contains:\nGlucose Oxidase (Aspergillus niger) 2 IU\nPotassium ferricyanide 1.5 mg\nNon-reactive ingredient 2.5 mg\nStabilizer 3.5 mg

• 關聯藥證數量: 1

Strip contains：Glucose Oxidase (Aspergillus niger) 2 IU, Potassium ferricyanide 1.5mg, Non-reactive ingredient 2.5mg, Stabilizer 3.5mg

• 關聯藥證數量: 1

Strip contains：\nGlucose Oxidase (Aspergillus niger) 2 IU\nPotassium ferricyanide 1.5 mg\nNon-reactive ingredient 2.5 mg\nStabilizer 3.5 mg

• 關聯藥證數量: 1

Strip: Glucose Oxidase (Aspergillus niger)≧0.7IU, Potassium ferricyanide≧0.02mg, Non-reactive ingredients≧0.12mg\n。Control solution: 2.5(w/w)% D-glucose, 97.5 (w/W)% Non-reactive ingredients。

• 關聯藥證數量: 1

Strip: Glucose Dehydrogenase with Flavin-Adenine Dinucleotide (GDH-FAD)≧1 IU, Non-reactive ingredients≧0.3 mg

• 關聯藥證數量: 1

Strip: Glucose oxidase (A. niger) 13%, Electron shuttle 39%, Enzyme protector 6%, Non-reactive ingredients 42% \nControl Solution: D-glucose 0.03%-0.30%, Inert ingredients >99.7%\n

• 關聯藥證數量: 1

Strip: Glucose oxidase (Aspergillus niger) ≥ 5.0%, electron shuttle 30%, enzyme stabilizer 5%, other ingredients 60%.\nControl Solution: 0.11% D-Glucose, Sodium benzoate 0.2%, EDTA 0.1%, Red dye 0.2%, Polymer 8.0%.

• 關聯藥證數量: 1

Strip: Glucose oxidase 10%, Electron shuttle 50%, Enzyme protector 8%, Non-reactive ingredients 32%\nControl solution: D-glucose 0.03-0.30%, Inert ingredient >99.7%

• 關聯藥證數量: 1

Strip: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl solution: D-glucose 0.03-0.30%、Inert ingredient 99.7%以上

• 關聯藥證數量: 1

Strip: Glucose oxidase≧1.2 IU, Non-reactive ingredients≧0.3 mg

• 關聯藥證數量: 1

Strip:Glucose Oxidase (A.niger)13%, Electron Shuttle 39%, Enzyme protector 6%, Non-reactive ingredients 42%, \nControl Solution:D-glucose 0.03%-0.30%, Inert ingredients>99.7%

• 關聯藥證數量: 1

Strip:Glucose Oxidase (Aspergillus niger)≧0.71U, Potassium ferricyanide≧0.02mg, Non-reactive ingredients≧0.12mg\nControl solution: 2.5 (w/w)% D-glucose, 97.5 (w/W)% Non-reactive ingredients

• 關聯藥證數量: 1

Strips: Glucose Oxidase 20 IU, Potassium ferricynide 0.12 mg, Non-reactive ingredients 1.8 mg

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%.\nControl solution: D-glucose 0.03-0.30%、Inert ingredient>99.7%.\n

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl: D-glucose 0.03-0.30% Inert ingredient>99.7%。\n

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl: D-glucose 0.03-0.30%、Inert ingredient >99.7%。

• 關聯藥證數量: 1

Strips: Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%，Control: D-glucose 0.03-0.30%、 Inert ingredient>99.7%。

• 關聯藥證數量: 1

Strips：Glucose oxidase： 14 Units\n Mediator (Potassium Ferricyanide)： 690 ug\n Buffer： 37 ug\n Stabilizer： 337ug\n Binder：1.4 ug

• 關聯藥證數量: 1

Strip：(GOD) Glucose Oxidase (Aspergillus Niger)：8%, Potassium ferricyanide：56.6%, Non-reactive ingredients：35.4%

• 關聯藥證數量: 1

Strip：Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32%\nControl：D-Glucose 0.03-0.30%、Inert ingredient > 99.7%

• 關聯藥證數量: 1

Strong Cetrimide Solution(BP) is an aqueous solution of cetrimide. It contains not less than 38.0% w/v and not more than 42.0% w/v (95.0% to 105.0% of 40% w/v solution) of cerimide, calculated as C17H38BrN. It contains Ethanol (96 per cent) or Isoptopyl Alcohol or both. It may be perfumed and may contain colouring matter.

• 關聯藥證數量: 1

Substance Low High\nBovine Serum Albumin 0.45g 0.3g\nTobramycin 0.06mg\nGentamicin 0.06mg\n

• 關聯藥證數量: 1

Substrate Reagent(R1):L-lithium lactate 8.23mg/mLCoenzyme Reagent(R2):β-nicotinamide adenine dinucleotide oxidation type (NAD) 15.4mg/mL

• 關聯藥證數量: 1

Substrate Reagent─5-bromo-4-chloro-3-indolyl phosphate and 0.1% sodium azide.

• 關聯藥證數量: 1

Substrate Sildes: Crithidia Iuciliae stabilized directly on the test wells. Positive Control: 1.0ml positive human control serum with antibody specific to nDNA antigens. Titratable Control Serum: 1.0ml positive human control serum. Negative Control Serum: 1.0ml negative human control serum. Fluorescent Antibody Reagent: 9.0ml Goat anti-human IgG (heavy and light chains) conjugated to fluorescein isothiocyanate (FITC). PBS Buffer Powder: Phosphate-buffered saline powder (0.01 M, pH 7.4±0.2).

• 關聯藥證數量: 1

Substrate Slides: Catalog No. 2007 (seven-well); 2013\n(thirteen-well): HEp-2 cells (with mitotic figures) grown and stabilized directly on the test wells. \n\nCatalog No. 2007-Ro (seven-well);\n2013-Ro (thirteen-well): HEp-2000R cells (with mitotic\nfigures) grown and stabilized directly on the test wells.\nThese are HEp-2 cells that have been stably transfected\nwith the SSA/Ro autoantigen. \n\nSSA/Ro Positive Control(Hep-2000 ANA Test Kit only)\n: Catalog No. 2035-Ro. Ready-to-use dropper vial containing \n1.0 ml positive human control serum with antibody specific to SSA/Ro antigens.\n\n

• 關聯藥證數量: 1

Substrate Slides: each slide well contains fixed Crithidia luciliae hemoflagellates.\nFluorescent Antibody Conjugate: Goat antihuman immunoglobulin conjugated with fluorescein isothiocyanate (FITC). ProClinTM 300, 0.05% w/v, is added as a preservative. Evans Blue is added as a counterstain.\nnDNA Positive Control Serum: Human serum in dropper vial containing anti-native DNA antibodies. Sodium azide, 0.1% w/v, is added as a preservative.\nAutoantibody Negative Control Serum: Human serum in dropper vial containing no detectable autoantibodies. Sodium azide, 0.1% w/v, is added as a preservative.\nPBS: Contains dry granular phosphate buffered saline blend.\nMounting Medium: Contains phosphate buffered glycerol with 0.05% w/v ProClinTM 300 added as a preservative.\n

• 關聯藥證數量: 1

Substrate Slides:Each HEp-2 well slide contains HEp-2 cell grown and fixed on the slide.Fluorescent Antibody Conjugate:Goat or rabbit (see vial label) anti-human immunoglobulin conjugated with fluroescein isothiocyanate (FITC). Evans Blue is added as a counterstain.ANA (Homogeneous) Positive Control Serum:Ready to use human serum in dropper vial containing antinuclear antibodies demonstrating a strong homogeneous staining reaction on HEp-2 cells.ANA (Homogeneous) Endopint Reference Control Serum:Ready to use human serum in dropper vial containing antinuclear antibodies demonstrating a minimal homogeneous staining reaction on HEp-2 cells.Autoantibody Negative Control Serum:Ready to use human serum in dropper vial containing no detectable autoantibodies. Sodium azide 0.1% is added as a presercative.PBS:Contains dry granular phosphate buffered saline blend.Mounting Medium:Ready to use dropper vial. Contains phosphate buffered glycerolBlotting Strips

• 關聯藥證數量: 1

Substrate-Enzyme：\n25 mmol/L Tris buffer,pH9.0\n200 mmol/L L-Alanine\n0.31 mmol/L NADH(yeast)\n12800 IU/L (37℃)LDH (microorganism)\nα-KG：\n260 mmol/L Tris buffer,pH4.8\n1150 mmol/L L-Alanine\n46.5 mmol/L α-Ketoglutarate

• 關聯藥證數量: 1

Substrate: Glucose, Sucrose, Sorbitol, Raffinose, Rhamnose, Arabinose, Inositol, Adonitol, Melibiose, Urea, Hydrogen Sulfide, Indole, Lysine, Arginine, Ornithine, Tryptophan Deaminase, Esculin, Voges-Proskauer, Citrate, Malonate, o-Nitrophenyl-β-D-Galactopyranoside, Tartrate, Acetamide, Cetrimide, OF Glucose, OF Base, Decarboxylase Base, Nitrate, Kanamycin, Colistin, Penicillin, Nitrofurantoin, Cephalothin, Tobramycin\nAntimicrobial: Amikacin, Amoxicillin/K Clavulanate, Ampicillin, Ampicillin/Sulbactam, Aztreonam, Cefazolin, Cefepime, Cefotaxime, Cefotaxime/K Clavulanate, Cefotetan, Cefoxitin, Ceftazidime, Ceftazidime/K Clavulanate, Ceftriaxone, Cefuroxime, Cephalothin, Ciprofloxacin, Ertapenem, Gentamicin, Imipenem, Levofloxacin, Meropenem, Moxifloxacin, Nitrofurantoin, Piperacillin/Tazobactam, Tetracydine, Ticarcillin/K Clavulanate, Tobramycin, Trimethoprim/Sulfamethoxazole

• 關聯藥證數量: 1

Substrate: Glucose-6-P 1mmol/l、\n NADP 0.75mmol/l、\n GGSG (oxidized glutathione) 0.8mmol/l、\nBuffer: Saponin 0.2%、\n Tris (hydroxymethyl)、\n Aminomethane 225mmol/l; pH7.8

• 關聯藥證數量: 1

Substrate:\nTris buffer 71.5 mmol/l, pH 8.25\nGlycylglycine 126 mmol/l\nL-r-glutamyl-p-nitroanilide 4 mmol/l\nSurfactants

• 關聯藥證數量: 1

Substrate：2-(Ethylamino) ethanol (EAE) buffer, pH9.9；4-Nitrophenylphosphate, disodium salt (4NPP)

• 關聯藥證數量: 1

Subtilisin A.....2.0mg\nSodium Chloride.....30.5mg\nTartaric acid.....17.2mg\nSodium Carbonate.....21.8mg\nSodium bicarbonate.....22.2mg\nPolyethyleneglycol 6000.....2.3mg\n以下空白

• 關聯藥證數量: 1

Succinate buffer 90 mmol/L\nBromocresol Green 0.26 mmol/L

• 關聯藥證數量: 1

Succinate buffer (pH 4.2) 100 mmol/l;\nBromocresol green 0.2 mmol/l;\nPreservative

• 關聯藥證數量: 1

Succinate buffer (pH4.2+-0.2) 75 mmol/L\nBromcresol green 0.15 mmol/L

• 關聯藥證數量: 1

Succinic Acid and 0.05% NaNO3

• 關聯藥證數量: 1

Succinylcholine Chloride contains not less than 96.0% and not more than 102.0% of C14H30Cl2N2O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sucralfate Humid Gel equivalent to Sucralfate

• 關聯藥證數量: 1

Sucralfate contains the equivalent of not less than 30% and not more than 38% of C12H14O35S8.

• 關聯藥證數量: 1

Sucralfate contains： - sucrose octasulfate (C12H14O35S88-)：30.0% to 36.0% - aluminium (Al)：16.5% to 18.5%

• 關聯藥證數量: 1

Sucralfate is the hydrous basic aluminum salt of sucrose octasulfate It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8).

• 關聯藥證數量: 1

Sucralfate is the hydrous basic aluminum salt of sucrose octasulfate. It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8)

• 關聯藥證數量: 1

Sucralfate is the hydrous basis aluminum salt of sucrose octasulfate. It contains the equivalent of not less than 30.0 percent and not more than 38.0 percent of sucrose octasulfate (C12H14O35S8).

• 關聯藥證數量: 1

Sugammadex Sodium contains not less than 95.0% and not more than 102.0% of C72H104Na8O48S8, calculated on anhydrous and solvent free basis.

• 關聯藥證數量: 1

Sugammadex contains not less than 89% and not more than 102% of C72H104O48S8Na8, and Sodium contains not less than 7% and not more than 9% of C72H104O48S8Na8 calculate on no anhydrous and no ethanol basis.

• 關聯藥證數量: 1

Sugammadex sodium contains not less than 96.0% and not more than 102.0% of C72H104O48S8Na8, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Sulbactam Sodium contains NLT 88.6% and NMT 94.1% of sulbactam (C8H11NO5S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulbactam Sodium contains not less than 886ug and not more than 941ug of Sulbactam (C8H11NO5S) per mg (on the anhydrous basis)

• 關聯藥證數量: 1

Sulfadiazine Silver contains not less than 98.0% and not more than 102.0% of C10H9AgN4O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfadiazine contains not less than 99.0 % and not more than the equivalent of 101.0 % of 4-amino-N-pyrimidin-2-ylbenzenesulphonamide, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfadiazine contains not less than 99.0% and not more than the equivalent of 101.0% of 4-amino-N-pyrimidin-2-ylbenzensulphonamide,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfadimidine contains not less than 99.0% and not more than the equivalent of 101.0% of C12H14N4O2S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfamethazine contains not less than 99.0% and not more than 100.5% of C12H14N4O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfamethoxazole Sodium Assay:98.0~100.5%

• 關聯藥證數量: 1

Sulfamethoxazole Sodium contains not less than 98.0% and not more than 100.5% of C10H10N3O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulfamethoxazole Sodium contains not less than 99.0% and not more than 100.5% of C10H10N3NaO3S (dried substance).

• 關聯藥證數量: 1

Sulfamethoxazole contains not less than 99.0% not more than the equivalent of 101.0% of C10H11N3O3S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulfamine

• 關聯藥證數量: 1

Sulfanilic acid：27 mmol/L HCL：51 mmol/L Sodium nitrite：0.12 mmol/L

• 關聯藥證數量: 1

Sulfasalazine contains not less than 97.0% and not more than 101.5% of C18H14N4O5S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulfasalazine contains not less than 97.0% and not more than 101.5% of C18H14N4O5S, calculated on the dried substance.

• 關聯藥證數量: 1

Sulfuric acid 10 mmol/L\nAmmonium molybdate 3.4 mmol/L

• 關聯藥證數量: 1

Sulindac contains 99.0%~101.0% of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0 percent and not more than 101.0 percent of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than 101.0% of C20H17FO3S, calcluated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than 101.0% of C20H17FO3S, calculated on the dried basis.

• 關聯藥證數量: 1

Sulindac contains not less than 99.0% and not more than the equivalent of 101.0% of C20H17FO3S,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulindac contains not less then 99.0% and not more then 101.0% of C20H17FO3S, Calculated on the dried basis

• 關聯藥證數量: 1

Sulphamethoxazole contains not less than 99.0% and not more than 101.0% of C10H11N3O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Sulphamethoxazole contains not less than 99.0% and not more than 101.0% of C10H11N3O3S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Sulphamethoxazole/Trimethoprim 25ug/disc

• 關聯藥證數量: 1

Sulphanilic acid 29 mmol/l\nSodium Nitrite 0.17 mol/l\nHydrochloric acid 38.5 mmol/l

• 關聯藥證數量: 1

Sulphur hexafluoride microbubbles

• 關聯藥證數量: 1

Sulphuric acid 200 mmol/l\nAmmoniumheptamolybdate 0.35mmol/l\nGlycine 50mmol/l\nPreservative

• 關聯藥證數量: 1

Sulpiride Content: 98.5 percent to 101.0% percent of C15H23N3O4S (dried substance).

• 關聯藥證數量: 1

Sulpiride contains 98.5% to 101.0% of C15H23N3O4S.(dried substance)

• 關聯藥證數量: 1

Sulpiride contains not less than 98.5% and not more than 101.0% of C15H23N3O4S calculated on the dried substance.

• 關聯藥證數量: 1

Sultamicillin tosilate hydrate

• 關聯藥證數量: 1

Sum of content of lincomycin hydrochloride (C18H35ClN2O6S, H2O) and lincomycin B hydrochloride (C17H35ClN2O6S, H2O): 96.0~102.0% (on anhydrous basis). Lincomycin B hydrochloride (C17H35ClN2O6S, H2O): not more than 5.0% (on anhydrous basis).

• 關聯藥證數量: 1

Sum of content of lincomycin hydrochloride and lincomycin B hydrochloride: 96.0 per cent to 102.0 per cent (anhydrous substance).Lincomycin B hydrochloride: maximum 5.0 per cent (anhydrous substance)

• 關聯藥證數量: 1

Super enhancer, Link, Label, DAB chromogen, DAB Buffer, Hematoxylin, Peroxide Block, AEC solution, Negative control for mouse, Negative control for rabbit.

• 關聯藥證數量: 1

SureStepFlexx

• 關聯藥證數量: 1

SureStepFlexx Operator's Guide

• 關聯藥證數量: 1

SureStepFlexx Quick Reference Guide

• 關聯藥證數量: 1

SureStepFlexx with Barcode Scanner

• 關聯藥證數量: 1

Surfactant 1%\nHydrochloric Acid 100 mmol/L\nSulphanilic acid 5 mmol/L

• 關聯藥證數量: 1

Surfactant, nonreactive ingredients

• 關聯藥證數量: 1

Surfactant\nWater

• 關聯藥證數量: 1

Survey ANA ANA-01-ANA-05\nSurvey ASO ASO-01- ASO-05\nSurvey CRP CRP-01 and CRP-02\nSurvey hCG hCG-01- hCG-05\nSurvey IM IM-01- IM05\nSurvey RF RF-01- RF-05\nSurvey RFX RF-01- RF-05(two each)\nSurvey RUB RUB-01- RUB-05\nSurvey RUBX RUB-01- RUB-05(two each)\nSurvey IL All specimens and analytes listed above\nSurvey IG IG-01- IG-10\nSurvey IGX IG-01- IG-10(two each)\n

• 關聯藥證數量: 1

Suspension of stabilized human red blood cells.

• 關聯藥證數量: 1

Synthetic Aluminum Silicate：The volume of 0.1mol/L hydrochloric acid VS consumed is not less than 55.0mL/g of Synthetic Aluminum Silicate.

• 關聯藥證數量: 1

Synthetic Hydrotalcite contains not less than 13% Al2O3 and not less than 31% of MgO.

• 關聯藥證數量: 1

Synthetic Hydrotalcite contains not less than 31.0% of magnesium oxide (MgO: 40.30) and not more than 13.0% of aluminum oxide (Al2O3: 101.96), and the molar ratios of magnesium oxide and aluminum oxide are between 6.30 and 5.20.

• 關聯藥證數量: 1

Synthetic, Calcium Hydroxylaptite(CaHA)Particles..30%\nSterile Water for injection, U.S.P...........................52%\nGlycerin, U.S.P...................................................15%\nSodium Carboxymethylcellulose (USP)...................3%\nRadiesse Particles 的直徑在25-45micromters

• 關聯藥證數量: 1

T <0.01% Amphetamine/Methamphetamine I I Fluorescein Tracer (3.5ml)

• 關聯藥證數量: 1

T3 Antibody-Coated Tubes：100 tubes/package T3 Tracer Solution：Less than 10 μCi (370 kBq) per bottle of Triiodothyronine [125 I] in barbital buffer with bovine serum albumin.T3 Reference Serum：Human serum with 0.1% sodium azide and other preservative.

• 關聯藥證數量: 1

T3 Standards:One vial, 1.0 ml, labeled A, containing 0 ng/dL and six vials, 0.5 mL each, labeled B-G, containing concentrations of approximately 25.0, 50.0, 100.0, 250.0, 500.0 and 1000.0 ng/dL T3 in huamn serum with sodium azide as a preservative.*DSL-3100 (500 Tubes) contains 3 sets of Standards. T3 [I-125] Reagent:One bottle in DSL-3100 (100 Tubes), 22 mL each, containing < 5 μCi (185 kBq) of [I-125]-labeled T3 in a protein-based (BSA) buffer with sodium azide as a preservative.*DSL-3100 (500 Tubes) contains five bottles of reagent. GAMG-Coated Tubes:One hundred (100) plastic tubes with goat anti-mouse gamma globulin immobilized to the inside wall of each tube.*DSL-3100 (500 Tubes) contains 500 tubes.

• 關聯藥證數量: 1

T3 Strips : \n Wells Reagents\n 1 Sample well.\n 2-3-4-5 Empty wells.\n 6 Conjugate : alkaline phosphatase labeled T3 derivative + ANS + sodium salicylate.\n 7-8-9 Wash buffer : Tris-Tween-NaCI (1 mmol/l) pH 7.4 \n 10 Cuvette with substrate : 4-methyl-ombelliferyl phosphate + diethanolamine (DEA)\n\nT3 SPRs : \nInterior of SPRs coated with anti-T3 monoclonal antibodies (sheep).\n\nT3 control : \nHuman serum + L-triiodothyronine.\n\nT3 calibrator : \nHuman serum + L-triiodothyronine.

• 關聯藥證數量: 1